4Filing Date: Sep 4, 2026
Resmed (RMD)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0000943819-26-000050
Total Value$227.7K
Trades1
Insiders1
Transaction Details
FARRELL PETER C
Director·Direct
Sell · Dispose
ResMed Common Stock
Shares-970
Price$234.73
Total Value$227.7K
Shares Owned After51.80K
Transaction DateSep 2, 2026
10b5-1
Footnotes ▸
The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
Post-Transaction Holdings
FARRELL PETER C · Director
| Security | Shares | Change |
|---|---|---|
| ResMed Common Stock | 51.80K | -970 (-1.84%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-02
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: RESMED INC (RMD)
CIK: 0000943819
--- Reporting Owner ---
Name: FARRELL PETER C
CIK: 0001186102
Role: Director
--- Non-Derivative Transactions ---
[Transaction #1]
Security: ResMed Common Stock
Date: 2026-09-02 | Code: S (Open market sale)
Shares: -970 | Price: $234.73
Total Value: $227,688.10
Shares Owned After: 51,803 | Ownership: D (Direct)
Footnotes:
[F1] The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
--- Footnotes (Complete Index) ---
F1: The transaction was conducted under a Rule 10b5-1 plan adopted August 12, 2025.
--- Signature ---
/s/ /s/ Peter C. Farrell, Chairman emeritus (2026-09-03)